MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Applied Protein Sciences, a biotechnology start-up focused on preventing mucositis, announced today that it has entered into a strategic alliance with Biomodels. This alliance allows speedier product development and helps APS expand its pipeline to develop proprietary drugs for mucositis, proctitis and IBD. APS expects to launch its clinical program later this year.
